The Israel plant protein market is estimated to grow at a CAGR of 9.85% to reach a market size of US$86.511 million in 2027 from US$44.808 million in 2020.
In the MEA regions, Israel is a nation that has given rise to and is still fueling a plethora of innovation and development geared towards bringing about a sustainable means of production of food. Furthermore, their growing young population is committed to relying on the nutritional value of plants. To this extent, it should be noted that in October 2019, Israel Chemicals, Ltd., announced its plans to invest about $20 million to expand manufacturing capacity and R&D support for its Rovitaris protein technology for the meat alternative market. Rovitaris' proprietary technology aims to support the development and production of allergen-free plant-based food products. ICL also claims that the ingredients can be adapted to any meat, poultry, or seafood alternative to improve taste and texture. It can also retain stability when frozen and thawed. That will aid in a substantial reduction in the manufacturing cost. In 2021, the Israeli plan protein market saw accelerated expansion with 450% YoY growth between 2020 and 2021 according to the Good Food Institute. In 2021, 11 new companies were established in the plant protein market in Israel.
The Israeli plant protein market is expected to grow due to its growing investment, willingness to partake in the research development of various plant-based protein alternatives, and others.
A team of researchers at Ben-Gurion University of the Negev (BGU) has revealed that Mankai, a high-protein form of the aquatic plant duckweed, could be the next superfood because it controls blood sugar levels after people eat carbohydrates. This is based on the fact that certain study participants received a Mankai shake and others a yogurt shake equivalent in carbohydrates, protein, lipids, and calories. After two weeks of monitoring with glucose sensors, it was inferred that participants who drank the duckweed shake displayed a much better response in a variety of measurements, including lower glucose peak levels; morning fasting glucose levels; later peak time; and faster glucose evacuation, as well as a fuller feeling. In 2021, Israel emerged as the global leader with 36% of global investment in cultivated proteins, it stood at second position in the world as a global alternative protein investment. And it stood first in the category of the world’s highest number of alternative seafood startups founded in 2021. Such developments project the immense growth of the Israeli plant protein market in the upcoming years.
Key Developments
COVID-19 Impact
The COVID-19 pandemic has created a shortage in the supply of animal proteins and has raised concerns regarding food security across the country. It has significantly boosted the alternative protein market due to shortfall and risk in the consumption of animal-based proteins. The countless benefits of plant-based protein such as helping in the reduction of viral infections due to the abundance of macronutrients, micronutrients, and antioxidants have aided the market growth. For instance, the Israeli plant-based protein funding stood at US$91 million in March 2022 and contributed higher to the overall food tech investment made in Israel. Thus, the plant-based protein market is expecting growth during the forecast period.
Segmentation